CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-13 | Gano Kyle Chief Executive Officer | Grant or award · Restricted Stock Unit | +20,142 | 20,142 | ||
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Option exercise | +2,017 | 50,634 | ||
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Shares withheld for taxes | −1,089 | $124.12 | $135K | 49,545 |
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Option exercise | +2,083 | 51,628 | ||
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Shares withheld for taxes | −1,124 | $124.12 | $140K | 50,504 |
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Grant or award | +9,968 | 60,472 | ||
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Shares withheld for taxes | −5,378 | $124.12 | $668K | 55,094 |
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Gift | −365 | 54,729 | ||
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Option exercise · Restricted Stock Unit | −2,017 | 4,036 | ||
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Option exercise · Restricted Stock Unit | −2,083 | 2,083 | ||
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Grant or award · Stock Option | +34,909 | 34,909 | ||
| 2026-02-13 | Lippoldt Darin Chief Legal Officer | Grant or award · Restricted Stock Unit | +6,124 | 6,124 | ||
| 2026-02-13 | GORMAN KEVIN CHARLES Director | Option exercise | +5,604 | 522,497 | ||
| 2026-02-13 | GORMAN KEVIN CHARLES Director | Shares withheld for taxes | −3,024 | $124.12 | $375K | 519,473 |
| 2026-02-13 | GORMAN KEVIN CHARLES Director | Option exercise | +5,377 | 524,850 | ||
| 2026-02-13 | GORMAN KEVIN CHARLES Director | Shares withheld for taxes | −2,901 | $124.12 | $360K | 521,949 |
| 2026-02-13 | GORMAN KEVIN CHARLES Director | Grant or award | +63,724 | 585,673 | ||
| 2026-02-13 | GORMAN KEVIN CHARLES Director | Shares withheld for taxes | −34,380 | $124.12 | $4.3M | 551,293 |
| 2026-02-13 | GORMAN KEVIN CHARLES Director | Option exercise · Restricted Stock Unit | −5,604 | 11,208 | ||
| 2026-02-13 | GORMAN KEVIN CHARLES Director | Option exercise · Restricted Stock Unit | −5,377 | 5,377 |
Page 12 of 49 · 963 trades